Table 5 Frequencies of adverse events (N = 85).

From: Combination use of intravenous ketamine-midazolam as a sedative agent in endoscopic retrograde cholangiopancreatography: a randomized control trial

 

Total

Study groups

P - Value

Ketamine-

Midazolam

Midazolam -

Pethidine

N = 85

N = 42

N = 43

Bradycardia

6

0

6

0.026

Elevation of BP

29

22

9

0.265

Hypertensive

24

17

7

Non hypertensive

7

5

2

Nausea

2

2

0

0.148

Hypoxia

4

0

4

0.241

Hypotension

2

0

2

0.494

Tachycardia

6

4

2

0.433

Back to article page